Every material Form 8-K Docusign filed with the SEC in 2025, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Docusign reported results for the quarter ended October 31, 2025, with revenue of $818.4 million, up 8% year over year, and GAAP diluted earnings of $0.40 per share, up from $0.30. The company also guided fourth-quarter revenue to $825 million to $829 million and full-year revenue to $3,208 million to $3,212 million, both implying 7% to 8% growth.
Subscription revenue was $801.0 million, up 9%; professional services and other revenue was $17.4 million, down 14%.
Non-GAAP diluted EPS was $1.01, up from $0.90; free cash flow was $262.9 million, up from $210.7 million.
Non-GAAP gross margin fell to 81.8% from 82.5% a year earlier.
Share repurchases totaled $215.1 million in the quarter.
Docusign reported results for the quarter ended July 31, 2025, with revenue of $800.6 million, up 9% year over year, while non-GAAP diluted earnings per share fell to $0.92 from $0.97. GAAP diluted EPS was $0.30 versus $4.26 a year earlier, a period that included a large income tax benefit. The company also named Mike Rosenbaum to its board and said James Beer will succeed Maggie Wilderotter as Board Chair at the end of the current fiscal year.
Revenue was $800.6 million, up 9% year over year; subscription revenue was $784.4 million
Non-GAAP diluted EPS was $0.92 versus $0.97; GAAP diluted EPS was $0.30 versus $4.26
Fiscal 2026 total revenue guidance is $3,189 million to $3,201 million, about 7% growth
Mike Rosenbaum joined the board effective September 3, 2025; James Beer named next Board Chair
Docusign reported results for its fiscal first quarter ended April 30, 2025, with revenue of $763.7 million, up 8% year over year, and GAAP diluted earnings of $0.34 per share, up from $0.16. The board also authorized an additional $1.0 billion for the stock repurchase program, bringing total remaining authorization to $1.4 billion as of June 5, 2025, which matters to shareholders as a potential source of share count reduction.
Q1 revenue was $763.7 million, up 8% year over year; subscription revenue was $746.2 million, up 8%
GAAP diluted EPS was $0.34 versus $0.16 a year earlier; non-GAAP diluted EPS was $0.90 versus $0.82
Board authorized up to $1.0 billion of additional repurchases; total remaining authorization is $1.4 billion as of June 5, 2025
Guidance: quarter ending July 31, 2025 revenue of $777 million to $781 million; fiscal year ending January 31, 2026 revenue of $3,151 million to $3,163 million
DocuSign entered into a credit agreement on May 21, 2025, providing a $750 million revolving credit facility led by Bank of America, with an option to increase it by $250 million. The company had no outstanding revolving loans under the facility as of May 21, 2025, so the agreement adds borrowing capacity rather than new debt. Shareholders should note the facility is secured by substantially all company assets and includes financial covenants and a change-of-control event of default.
Revolving credit facility of $750 million, expandable by an additional $250 million
Facility matures May 21, 2030; no revolving loans were outstanding as of May 21, 2025
Secured by a first priority interest in substantially all assets of the company and certain subsidiaries
Covenants include a maximum leverage ratio of 3.75:1.00 before an investment grade period
Docusign disclosed that director Daniel Springer notified the company on April 24, 2025 that he is resigning from its Board of Directors, effective immediately. The filing states he is not resigning due to any disagreement with the company on its operations, policies or practices.
Daniel Springer notified Docusign of his board resignation on April 24, 2025.
The resignation is effective immediately.
The filing states there was no disagreement with the company on operations, policies or practices.
Docusign reported fourth-quarter and fiscal 2025 results for the periods ended January 31, 2025, with total revenue up 9% in the quarter and 8% for the year. The company also issued revenue guidance for the quarter ending April 30, 2025 and for fiscal 2026, which shareholders can use as a reference point for future results.
Q4 GAAP diluted EPS was $0.39 versus $0.13 a year earlier; non-GAAP diluted EPS was $0.86 versus $0.76.
Fiscal 2025 GAAP net income was $1.07 billion, including an income tax benefit of $819.9 million; GAAP diluted EPS was $5.08 versus $0.36.
Guidance: quarter ending April 30, 2025 total revenue of $745 million to $749 million; fiscal 2026 total revenue of $3,129 million to $3,141 million.
Fiscal 2025 stock repurchases were $683.5 million, compared with $145.5 million a year earlier.
On January 15, 2025, DocuSign's Compensation and Leadership Development Committee approved amended and restated severance and change in control agreements for CFO Blake Grayson, Robert Chatwani and Chief Legal Officer James Shaughnessy. The new agreements make permanent severance enhancements that were set to expire on December 31, 2024, and they set out the payments owed on qualifying terminations.
Agreements cover CFO Blake Grayson, Robert Chatwani (President and General Manager, Growth) and Chief Legal Officer James Shaughnessy.
Outside a change in control period, a qualifying termination provides 12 months of base salary, a 100% target bonus, 12 months of COBRA coverage and 12 months of equity vesting acceleration.
During a change in control period (90 days before to 12 months after a change in control), the terms are 12 months of base salary, a 100% target bonus, 12 months of COBRA coverage and 100% equity vesting acceleration.
The agreements are not employment contracts, and payments are subject to the officer signing a release of claims.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Docusign filing is on SEC EDGAR ↗. 8-K briefs of other companies →